Skip to main content

CAPITAL MANAGEMENT CORP /VA

Position in ANIK — Anika Therapeutics, Inc.

CIK 1074273 GLEN ALLEN, VA

Position in ANIK

as of Mar 31, 2026 · filed Apr 23, 2026
Position Value
$6,491,954
+$1,682,486 QoQ
Shares Held
447,721
-10.5% QoQ
Ownership
3.36%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CAPITAL MANAGEMENT CORP /VA holds $6,491,954 across 1 Drug Manufacturers - Specialty & Generic name. ANIK ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ANIK
Anika Therapeutics, Inc.
This page
447,721 $6,491,954

All Filings in ANIK

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,491,954 447,721
2025-12-31 $4,809,468 500,465
2025-09-30 $5,181,731 551,248
2025-06-30 $4,325,580 408,845
2025-03-31 $4,954,789 329,660
2024-12-31 $5,358,470 325,545
2024-09-30 $7,171,645 290,350
2024-06-30 $8,323,944 328,620
2024-03-31 $9,246,235 364,025
2023-12-31 $8,056,400 355,534
2023-09-30 $1,569,111 84,225
2022-09-30 $2,436,882 102,390
2022-06-30 $6,140,901 275,130
2022-03-31 $5,078,698 202,258
2021-12-31 $4,760,015 132,850
2021-09-30 $5,042,934 118,490
2021-06-30 $4,298,913 99,305
2021-03-31 $5,927,194 145,310
2020-12-31 $4,210,764 93,035
2020-09-30 $3,356,033 94,830
2020-06-30 $6,759,367 179,151
2020-03-31 $2,685,883 92,905